Efficacy News and Research

RSS
New analyses from Phase III studies of VICTRELIS to be presented at AASLD 2011

New analyses from Phase III studies of VICTRELIS to be presented at AASLD 2011

Vertex announces abstracts from hepatitis C program to be presented at The Liver Meeting

Vertex announces abstracts from hepatitis C program to be presented at The Liver Meeting

Baxter seeks European marketing authorization for HyQ to treat PI

Baxter seeks European marketing authorization for HyQ to treat PI

JenaValve's transapical TAVI system receives CE mark approval to treat aortic valve stenosis

JenaValve's transapical TAVI system receives CE mark approval to treat aortic valve stenosis

Four teams receive commercialization grant awards for development of new health-care products

Four teams receive commercialization grant awards for development of new health-care products

Array announces results from selumetinib Phase 2 combination study on KRAS-mutant NSCLC

Array announces results from selumetinib Phase 2 combination study on KRAS-mutant NSCLC

Enrollment begins in Boston Scientific's vagal nerve stimulation trial for heart failure

Enrollment begins in Boston Scientific's vagal nerve stimulation trial for heart failure

Almirall seeks European approval for linaclotide to treat irritable bowel syndrome with constipation

Almirall seeks European approval for linaclotide to treat irritable bowel syndrome with constipation

Appalachia pediatricians less likely to encourage HPV vaccination than other area doctors

Appalachia pediatricians less likely to encourage HPV vaccination than other area doctors

Positive new data from Otonomy's OTO-104 Phase 1b study on Meniere's disease

Positive new data from Otonomy's OTO-104 Phase 1b study on Meniere's disease

WSJ: Federal judge advances medical records case

WSJ: Federal judge advances medical records case

Almirall submits linaclotide MAA to EMA for treatment of IBS-C

Almirall submits linaclotide MAA to EMA for treatment of IBS-C

VOICE HIV prevention trial to discontinue use of tenofovir tablets

VOICE HIV prevention trial to discontinue use of tenofovir tablets

JIA program effective in changing unhealthy youth behaviors

JIA program effective in changing unhealthy youth behaviors

Study links pain severity with depression

Study links pain severity with depression

Enrollment complete in Rexahn's Archexin Phase II trial for metastatic pancreatic cancer

Enrollment complete in Rexahn's Archexin Phase II trial for metastatic pancreatic cancer

SanBio initiates SB623 Phase 1/2a clinical trial in ischemic stroke

SanBio initiates SB623 Phase 1/2a clinical trial in ischemic stroke

More of saw palmetto does not reduce urinary symptoms related to BPH

More of saw palmetto does not reduce urinary symptoms related to BPH

YM BioSciences begins enrollment in CYT387 Phase II trial for myelofibrosis

YM BioSciences begins enrollment in CYT387 Phase II trial for myelofibrosis

Americans cutting back on health spending by skipping prescriptions, procedures

Americans cutting back on health spending by skipping prescriptions, procedures

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.